News

TTAM Research Institute acquires 23andMe in a $305 million bankruptcy sale, transitioning the DNA testing giant to a ...
Anne Wojcicki on genetic privacy, data security, her bid for 23andMe Why California wants to stop 23andMe's sale to former ...
After the company filed for bankruptcy in March, this week, the sale of 23andMe was completed after previously being approved by a judge.
Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. A 23andMe saliva collection kit is shown on March ...
DNA from 23andMe after it declared bankruptcy. Now the more than 10 million remaining customers should delete theirs, too.
A U.S. bankruptcy judge has cleared 23andMe’s $305 million sale to TTAM Research, a nonprofit led by co-founder Anne Wojcicki ...
Me Holding said Tuesday that a U.S. bankruptcy court has approved the sale of “substantially all” its assets to TTAM Research Institute, a California-based nonprofit led by company co-founder and ...
Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron Pharmaceuticals' offer for the DNA-testing company in a bankruptcy auction.
23andMe CEO Anne Wojcicki has been trying to take the DNA testing company private this past year, making clear along the way that she would oppose any deal to sell the business to someone else.
Anne Wojcicki's winning bid to reclaim control of 23andMe doesn't necessarily end the fight over what happens to the DNA of 15 million people collected by the bankrupt consumer genomics company.
23andMe Holding Co. Chief Executive Officer Anne Wojcicki has offered to take the struggling DNA-testing company private. Wojcicki on July 29 proposed buying the outstanding shares of 23andMe for ...
(Reuters) -Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron Pharmaceuticals' offer for the DNA-testing company in a ...